Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Feb 22, 2021 7:00 AM - Feb 24, 2021 8:00 PM

(Eastern Standard Time)

Latin America Regulatory Conference

Session 7: How Can Clinical Trial Innovative Designs Accelerate Medical Innovation for Patients?

Session Chair(s)

Sonia  Viejobueno, LLM

Sonia Viejobueno, LLM

Associate Director, Regulatory Policy LATAM

Johnson & Johnson Innovative Medicine, Argentina

Renata De Lima Soares

Renata De Lima Soares

Regulation and Health Surveillance Specialist

Anvisa, Brazil

In contrast to traditional trial designs, where a single drug is tested in a single disease population in one clinical trial, designs such as master protocols use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple sub-studies, that may contain an adaptive design.
We will discuss Innovative Clinical Trials design, including Basket, Umbrella, Platform and Adaptive Clinical Trials and how they are contributing to accelerate patient access to new medicines and improve the efficiency and the success rate of clinical trials.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand basic concepts of Innovative Clinical Trials Design and their importance for current drug development
  • Obtain greater understanding of Innovative Clinical Trials Design and how can industry and regulators across Latin America collaborate to support their implementation in the region

Speaker(s)

John  Scott, PhD, MA

John Scott, PhD, MA

FDA, United States

Division Director, Office of Biostatistics, CBER

Laura Giselle Traversi, MD

Clinical Trial Innovative designs: Regulatory Agency Perspective

Laura Giselle Traversi, MD

ANMAT, Argentina

Head of Clinical Trials Department

Gustavo  Mendes Lima Santos, MPharm

Speaker

Gustavo Mendes Lima Santos, MPharm

Brazilian Health Regulatory Agency (ANVISA), Brazil

Herbal and Complementary Medicines Office - GMESP

Telba  Irony, PhD, MS, MSc

Speaker

Telba Irony, PhD, MS, MSc

Janssen R&D, United States

Senior Scientific Director, Quantitative Sciences

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.